Search
Menu
Meadowlark Optics - SEE WHAT

PerkinElmer to Market Newborn Screening System

Facebook X LinkedIn Email
BOSTON, Nov. 14 -- PerkinElmer Inc., the leading provider of solutions to newborn screening laboratories, said it is the first company to receive FDA 510(k) clearance to market a comprehensive screening system to identify whether a newborn may become developmentally impaired or risk premature death. PerkinElmer's NeoGram Phenylalanine Test System, consisting of a reagent kit, application software and tandem mass spectrometer, will be used to identify a disorder known as phenylketonuria (PKU) in newborns.

The reagent kit is designed to run exclusively on tandem mass spectrometry equipment, a new technology for newborn screening, PerkinElmer said.

For more information, visit: lifesciences.perkinelmer.com

PI Physik Instrumente - Revolution In Photonics Align ROS MR 3/24

Published: November 2002
News & Featuresspectroscopy

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.